Speaker

Jun 15-16, 2026    Paris, France
10th International Conference on

COPD and Lung Health

Grishma Desai
11:40 AM-12:00 PM 307

Grishma Desai

Title: Efficacy of Grignard Pure Against a Variety of Bioaerosols

Biography:

Grishma Desai is multifaceted Scientist and Quality Manager at Grignard Company LLC with experience in Biological Nutrient Removal (BNR), wastewater mineral removal and US EPA Pesticide Testing and Regulations. She has a Bachelor’s of Science in Biotechnology from Rutgers University, New Jersey, USA. During her eight years at Grignard Company, she has led multiple R&D efforts in new product development as well as regulatory compliance for products.  In the past two years, Ms. Desai’s work has focused on developing, testing and obtaining regulatory approvals for Grignard Pure® – an airborne antimicrobial effective against MS2 Bacteriophage, a surrogate for the SARS-CoV-2 as well as other bioaerosols. Ms. Desai worked closely with Dr Katherine Ratliff and her team at the US EPA Office of Research and Development to evaluate the efficacy of Grignard Pure® in reducing airborne virus concentrations using a large-scale test chamber and a standardized testing approach. Ms. Desai recently submitted a paper titled “The efficiency of Grignard Pure to inactivate airborne SARS-CoV-2 surrogate” to a peer reviewed journal detailing the testing conducted on Grignard Pure at independent testing labs.